Ventyx Biosciences, Inc. (29)

Browse by Contract Category

Contracts

Form of Registration Rights Agreement, dated September 17, 2022, by and among the Company and the Purchasers (Filed With SEC on September 19, 2022)
Lease by and between Charlotta Partners, Inc. and the Company, dated April 25, 2022 (Filed With SEC on August 15, 2022)
Executive Change in Control and Severance Plan (Filed With SEC on May 9, 2022)
Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on March 24, 2022)
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Martin Auster, M.D. and the Registrant (Filed With SEC on October 15, 2021)
Form of Stock Purchase Agreement, dated September 17, 2022, by and among the Company and the Purchasers (Filed With SEC on September 19, 2022)
Employment Letter between the Company and Dr. Sandborn, dated May 5, 2022 (Filed With SEC on May 9, 2022)
Description of Common Stock (Filed With SEC on March 24, 2022)
2021 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 18, 2021)
2019 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 18, 2021)
Standard Multi-Tenant Office Lease, dated as of September 15, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant (Filed With SEC on October 15, 2021)
Confirmatory Offer Letter, dated as of October 7, 2021, by and between the Registrant and Jrn Drappa, M.D., Ph.D (Filed With SEC on October 15, 2021)
Master Services Agreement, dated as of January 17, 2019, by and between the Registrant and Bayside Pharma, LLC (Filed With SEC on October 15, 2021)
Lease, dated as of June 14, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant (Filed With SEC on October 15, 2021)
Confirmatory Offer Letter, dated as of October 7, 2021, by and between John Nuss, Ph.D. and the Registrant (Filed With SEC on October 15, 2021)
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Christopher Krueger, J.D., M.B.A. and the Registrant (Filed With SEC on October 15, 2021)
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Raju Mohan, Ph.D. and the Registrant (Filed With SEC on October 15, 2021)
2021 Employee Stock Purchase Plan, to be in effect upon the completion of this offering (Filed With SEC on October 15, 2021)
2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on October 15, 2021)
Specimen common stock certificate of the Registrant (Filed With SEC on October 15, 2021)
Form of Underwriting Agreement, including form of Lock-up Agreement (Filed With SEC on October 15, 2021)
Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Zomagen Biosciences Ltd. and certain of its Securityholders (Filed With SEC on September 29, 2021)
Offer Letter, dated as of May 21, 2021, by and between William R. White, J.D., M.P.P. and the Registrant (Filed With SEC on September 29, 2021)
Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on September 29, 2021)
2019 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 29, 2021)
Form of Indemnification Agreement (Filed With SEC on September 29, 2021)
Amended and Restated Investors Rights Agreement, dated as of September 9, 2021, by and among the Registrant and certain of its Stockholders (Filed With SEC on September 29, 2021)
Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Oppilan Pharma Ltd. and certain of its Securityholders (Filed With SEC on September 29, 2021)
Asset Purchase Agreement, dated as of February 7, 2019, by and between Vimalan Biosciences, Inc. and the Registrant (Filed With SEC on September 29, 2021)